Showing results (41-50 of 102) with videos related to
Sort By:
Pageof 11
Journal of Microbiology (Seoul, Korea)|September 3, 2011
Characterization of nitrogen-fixing bacteria isolated from field-grown barley, oat, and wheatAnastasia Venieraki, Maria Dimou, Eleni Vezyri, et al.Molecular Plant-Microbe Interactions : MPMI|December 16, 2004
Induction and spatial organization of polyamine biosynthesis during nodule development in Lotus japonicusEmmanouil Flemetakis, Rodica C Efrose, Guilhem Desbrosses, et al.Plants (Basel, Switzerland)|February 12, 2020
Thymus Citriodorus (Schreb) Botanical Products as Ecofriendly Nematicides with Bio-Fertilizing PropertiesNikoletta Ntalli, Athanasia Bratidou Parlapani, Kaliopi Tzani, et al.Journal of Clinical Medicine|February 26, 2025
Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature ReviewMaria Dimou, Angelo Vacca, Silvia Sánchez-Ramón, et al.Molecular Plant-Microbe Interactions : MPMI|May 25, 2002
Lotus japonicus gene Ljsbp is highly conserved among plants and animals and encodes a homologue to the mammalian selenium-binding proteinsEmmanouil Flemetakis, Adamantia Agalou, Nektarios Kavroulakis, et al.Advances in Hematology|March 4, 2024
The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic ReviewSevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Nefeli Giannakopoulou, et al.Plant Physiology|May 1, 2009
Molecular and biochemical characterization of the parvulin-type PPIases in Lotus japonicusEvangelia D Kouri, Nikolaos E Labrou, Spiros D Garbis, et al.Journal of Clinical Immunology|April 10, 2023
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO StudyMichael Borte, Leif G Hanitsch, Nizar Mahlaoui, et al.Anticancer Research|July 5, 2018
Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective AnalysisMaria Dimou, Theodore Iliakis, Dimitrios Maltezas, et al.Clinical Case Reports|May 3, 2021
Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment?Maria Dimou, Aikaterini Bitsani, Maria Roumelioti, et al.Pageof 11